1. "2009"
Formats
  1. Journal Article (1884)
  2. Meeting Abstract (566)
  3. Book Section (195)
  4. Conference Paper (22)
  5. Book Whole (16)
Groups
  1. Department of Medicine (784)
  2. Surgery (698)
  3. GSK Faculty (533)
  4. Sloan Kettering Institute Faculty (480)
  5. Solid Tumor Oncology Division (413)
  6. Survivorship Research (335)

More Groups

People
  1. Dennis Chi (53)
  2. Richard Barakat (51)
  3. Peter Scardino (47)
  4. Nadeem Abu-Rustum (44)
  5. Valerie Rusch (44)
  6. Yuman Fong (41)

More People

Years
  1. 2009 (2683)
Publications
  1. Journal of Clinical Oncology (219)
  2. Cancer Research (84)
  3. Blood (82)
  4. Gynecologic Oncology (64)
  5. Cancer Rehabilitation: Principles and Practice. 1st ed (51)
  6. Journal of Thoracic Oncology (44)

More Publications

Publishers
  1. Elsevier Inc. (297)
  2. American Society of Clinical Oncology (222)
  3. Elsevier Science, Inc. (164)
  4. Lippincott Williams & Wilkins (144)
  5. American Association for Cancer Research (143)
  6. Springer (137)

More Publishers

Results (2683)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer
    Meeting Abstract

    Flaherty, K.; Puzanov, I.; Sosman, J.; Kim, K.; Ribas, A.; McArthur, G.; Lee, R. J.; Grippo, J. F.; Nolop, K.; Chapman, P.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTC) in patients with metastatic castration-resistant prostate cancer (CRPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy
    Meeting Abstract

    Fleisher, M.; Danila, D. C.; Leversha, M.; Rathkopf, D.; Slovin, S.; Anand, A.; Koscuiszka, M.; Haqq, C.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803
    Meeting Abstract

    Fuchs, C.; Ogino, S.; Meyerhardt, J. A.; Irahara, N.; Niedzwiecki, D.; Hollis, D.; Saltz, L. B.; Mayer, R. J.; Bertagnolli, M. M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Prevalence of paroxysmal nocturnal hemoglobinuria (PNH) cells in patients with myelodysplastic syndromes (MDS), aplastic anemia (AA), or other bone marrow failure (BMF) syndromes: Interim results from the EXPLORE trial
    Meeting Abstract

    Galili, N.; Ravandi, F.; Palermo, G.; Bubis, J.; Illingworth, A.; Castro-Malaspina, H.; Raza, A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II study of sunitinib on a continuous dosing schedule in patients (pts) with relapsed or refractory urothelial carcinoma (UC)
    Meeting Abstract

    Gallagher, D. J.; Milowsky, M. I.; Gerst, S. R.; Tickoo, S.; Ishill, N.; Regazzi, A.; Trout, A.; Bajorin, D. F.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Frequency of use and outcome of surgical resection in the management of malignant mesothelioma in a community-based population: Results in 5,937 patients
    Meeting Abstract

    Flores, R. M.; Riedel, E.; Donington, J. S.; Krug, L.; Rosenzweig, K.; Adusumilli, P.; Carbone, M.; Rusch, V. W.; Pass, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts
    Meeting Abstract

    Feldman, D. R.; Sheinfeld, J.; Bajorin, D. F.; Fischer, P.; Turkula, S.; Ishill, N.; Patil, S.; Bains, M.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Synchronous and metachronous bilateral breast cancer: Are the risks greater in women with a history of radiation for Hodgkin lymphoma?
    Meeting Abstract

    Elkin, E. B.; Gonzales, A. R.; Ishill, N. M.; Klem, M. L.; Hodgson, D.; Ng, A. K.; Marks, L. B.; Weidhaas, J.; Freedman, G. M.; Miller, R. C.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pancyclin-dependentkinase (CDK) inhibitor flavopiridol
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M.; Tse, A. N.; Dials, H.; Cane, L. M.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Incidence of adnexal and lymph node metastases in endometrial stromal sarcoma
    Meeting Abstract

    dos Santos, L.; Garg, K.; Diaz, J. P.; Soslow, R. A.; Hensley, M. L.; Alektiar, K. M.; Barakat, R. R.; Leitao, M. M. Jr
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save